Form 4: Nkarta Inc. Executive Sells Shares to Cover Tax Obligations

David Shook, Chief Medical Officer at Nkarta, Inc., sold 8,638 shares of common stock to cover tax obligations related to vesting Restricted Stock Units.

Summary

• David Shook, the Chief Medical Officer and Head of Research & Development at Nkarta, Inc., sold 8,638 shares of common stock on January 15, 2025.
• The sale was executed at a price of $2.2 per share.
• This transaction was not a discretionary sale but was required to cover tax withholding obligations associated with the vesting of Restricted Stock Units.
• Following the transaction, Mr. Shook directly owns 190,955 shares of Nkarta, Inc. common stock.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction for tax purposes, not indicative of positive or negative sentiment towards the company's performance.

Industry Context

This is a routine transaction for executives who receive stock-based compensation. It is common for executives to sell shares to cover tax obligations when restricted stock units vest.

Comparison to Industry Standards

• Sales of shares by executives to cover tax obligations are a common practice across the biotechnology industry.
• Many companies use restricted stock units as part of their compensation packages, leading to similar transactions when these units vest.
• The number of shares sold and the price are specific to Nkarta and the executive's compensation package, making direct comparisons difficult without further context.

Stakeholder Impact

• The sale of shares by an executive may have a minor impact on the stock price, but it is generally considered a routine transaction.
• The transaction does not indicate any change in the company's operations or outlook.

Key Dates

Keywords

Nkarta Inc., David Shook, stock sale, insider trading, restricted stock units, tax obligations, NKTX, Chief Medical Officer